Search Results

Management of chronic hepatitis C patients who have relapsed or not responded to pegylated interferon alfa plus ribavirin

Authors: Dieterich, D. T.; Rizzetto, M.; Manns, M. P.

Source: Journal of Viral Hepatitis, Volume 16, Number 12, December 2009 , pp. 833-843(11)

Publisher: Blackwell Publishing

Evidence for action of ribavirin through the hepatitis C virus RNA polymerase

Authors: Cannon, N. A.; Donlin, M. J.; Mayes, L. M.; Lyra, A. C.; Di Bisceglie, A. M.; Tavis, J. E.

Source: Journal of Viral Hepatitis, Volume 16, Number 8, August 2009 , pp. 595-604(10)

Publisher: Blackwell Publishing

Thiazolides: a new class of drugs for the treatment of chronic hepatitis B and C

Authors: Rossignol, Jean-François; Keeffe, Emmet B

Source: Future Microbiology, Volume 3, Number 5, October 2008 , pp. 539-545(7)

Publisher: Future Medicine

Refined analysis of genetic variability parameters in hepatitis C virus and the ability to predict antiviral treatment response

Authors: Cuevas, J. M.; Torres-Puente, M.; Jiménez-Hernández, N.; Bracho, M. A.; García-Robles, I.; Carnicer, F.; Olmo, J. D.; Ortega, E.; Moya, A.; González-Candelas, F.

Source: Journal of Viral Hepatitis, Volume 15, Number 8, August 2008 , pp. 578-590(13)

Publisher: Blackwell Publishing

Genetic variability in hepatitis C virus and its role in antiviral treatment response

Authors: Torres-Puente, M.; Cuevas, J. M.; Jiménez-Hernández, N.; Bracho, M. A.; García-Robles, I.; Wrobel, B.; Carnicer, F.; del Olmo, J.; Ortega, E.; Moya, A.; González-Candelas, F.

Source: Journal of Viral Hepatitis, Volume 15, Number 3, March 2008 , pp. 188-199(12)

Publisher: Blackwell Publishing

Studies of Therapy with Thymosin α1 in Combination with Pegylated Interferon α2a and Ribavirin in Nonresponder Patients with Chronic Hepatitis C

Authors: CAMERINI, ROBERTO; CIANCIO, ALESSIA; DE ROSA, ALFONSO; RIZZETTO, MARIO

Source: Annals of the New York Academy of Sciences, Volume 1112, Number 1, September 2007 , pp. 368-374(7)

Publisher: Blackwell Publishing

Incidence of psychiatric side effects during pegylated interferon- α retreatment in nonresponder hepatitis C virus-infected patients

Authors: Quarantini, Lucas C.; Bressan, Rodrigo A.; Galvão, Amanda; Batista-Neves, Susana; Paraná, Raymundo; Miranda-Scippa, Ângela

Source: Liver International, Volume 27, Number 8, October 2007 , pp. 1098-1102(5)

Publisher: Blackwell Publishing

A randomized trial of induction doses of interferon alone or in combination with ribavirin or ribavirin plus amantadine for treatment of nonresponder patients with chronic hepatitis C

Authors: Gramenzi, Annagiulia; Andreone, Pietro; Cursaro, Carmela; Verucchi, Gabriella; Boccia, Sergio; Giacomoni, Pier Luigi; Galli, Silvia; Furlini, Giuliano; Biselli, Maurizio; Lorenzini, Stefania; Attard, Luciano; Bonvicini, Fiorenza; Bernardi, Mauro

Source: Journal of Gastroenterology, Volume 42, Number 5, May 2007 , pp. 362-367(6)

Publisher: Springer

Longitudinal evaluation of a fibrosis index combining MMP-1 and PIIINP compared with MMP-9, TIMP-1 and hyaluronic acid in patients with chronic hepatitis C treated by interferon-alpha and ribavirin

Authors: Trocme, C.; Leroy, V.; Sturm, N.; Hilleret, M.-N.; Bottari, S.; Morel, F.; Zarski, J.-P.

Source: Journal of Viral Hepatitis, Volume 13, Number 10, October 2006 , pp. 643-651(9)

Publisher: Blackwell Publishing

Successful Treatment With Novel Triple Drug Combination Consisting of Interferon-γ, Interferon Alfacon-1, and Ribavirin in a Nonresponder HCV Patient to Pegylated Interferon Therapy

Authors: Balan, Vijayan; Rosati, Marianne; Anderson, Machiko; Rakela, Jorge

Source: Digestive Diseases and Sciences, Volume 51, Number 5, May 2006 , pp. 956-959(4)

Publisher: Springer

Pilot study of interferon-α–ribavirin–interleukin-2 for treatment of nonresponder patients with severe liver disease infected by hepatitis C virus genotype 1

Authors: Alric, L.; Thebault, S.; Peron, J.-M.; Balard, P.; Metivier, S.; Pipy, B.; Izopet, J.; Vinel, J.-P.

Source: Journal of Viral Hepatitis, Volume 13, Number 2, February 2006 , pp. 139-144(6)

Publisher: Blackwell Publishing

Pegylated Interferon -2a With or Without Ribavirin in HCV/HIV Coinfection: Partially Blinded, Randomized Multicenter Trial

Authors: Khalili, Mandana; Bernstein, David; Lentz, Ellen; Barylski, Christine; Hoffman-Terry, Margaret

Source: Digestive Diseases and Sciences, Volume 50, Number 6, June 2005 , pp. 1148-1155(8)

Publisher: Springer

Pegylated Interferon -2b, Ribavirin and Amantadine for Chronic Hepatitis C

Authors: Younossi, Zobair; McCullough, Arthur; Barnes, David; Post, Anthony; Ong, Janus; O’shea, Robert; Martin, Lisa; Bringman, Diane; Farmer, Denise; Levinthal, Gavin; Mullen, Kevin; Carey, William; Tavill, Anthony; Ferguson, Roy; Gramlich, Terry

Source: Digestive Diseases and Sciences, Volume 50, Number 5, May 2005 , pp. 970-975(6)

Publisher: Springer

Treatment of acute hepatitis C infection in HIV-infected patients: a retrospective analysis of eleven cases

Authors: M. Vogel; B. Bieniek; H. Jessen; C. K. Schewe; C. Hoffmann; A. Baumgarten; A. Kroidl; J. R. Bogner; U. Spengler; J. K. Rockstroh

Source: Journal of Viral Hepatitis, Volume 12, Number 2, March 2005 , pp. 207-211(5)

Publisher: Blackwell Publishing

The effect of adherence to therapy on sustained response in daily or three times a week interferon alpha-2b plus ribavirin treatment of naïve and nonresponder chronic hepatitis C patients

Authors: M. Raptopoulou; D. Tsantoulas; I. Vafiadi; I. Ketikoglou; E. Paraskevas; T. Vassiliadis; S. Kanatakis; G. Hatzis; L. Sidiropoulos; E. Akriviadis

Source: Journal of Viral Hepatitis, Volume 12, Number 1, January 2005 , pp. 91-95(5)

Publisher: Blackwell Publishing

A randomized trial of prolonged high dose of interferon plus ribavirin for hepatitis C patients nonresponders to interferon alone

Authors: G. Fattovich; I. Zagni; M. L. Ribero; E. Castagnetti; E. Minola; L. Lomonaco; C. Scattolini; P. Fabris; S. Boccia; M. Giusti; G. Abbati; M. Felder; P. Rovere; A. Redaelli; A. Tonon; A. Tomba; R. Montanari; C. Paternoster; M. Distasi; G. Fornaciari; G. Tositti; C. Rizzo; S. Suppressa; M. Pantalena; F. Noventa; A. Tagger

Source: Journal of Viral Hepatitis, Volume 11, Number 6, November 2004 , pp. 543-551(9)

Publisher: Blackwell Publishing

First phase hepatitis c viral kinetics in previous nonresponders patients

Authors: Cotler, S. J.; Layden, J. E.; Neumann, A. U.; Jensen, D. M.

Source: Journal of Viral Hepatitis, Volume 10, Number 1, January 2003 , pp. 43-49(7)

Publisher: Blackwell Publishing

Dynamics of hepatitis C virus quasispecies turnover during interferon- treatment

Authors: Wagner M.; Lee J.-H.; Rüster B.; Kronenberger B.; Sarrazin C.; Roth W.K.; Zeuzem S.

Source: Journal of Viral Hepatitis, Volume 10, Number 6, November 2003 , pp. 413-422(10)

Publisher: Blackwell Publishing

Peginterferon alfa-2A (40KD) (PEGASYS) plus ribavirin (RBV) and amantadine (AMA) vs induction therapy with interferon alfa-2A (roferon-A) plus RBV and AMA in IFN/RBV nonresponder patients with chronic hepatitis C (CHC)

Authors: Fargion S.; Borzio M.; Cargnel A.

Source: Journal of Hepatology, Volume 38, Supplement 2, April 2003 , pp. 139-140(2)

Publisher: Elsevier

Reinforced interferon alpha-2b and ribavirin is more effective than standard combination therapy in the retreatment of chronic hepatitis C previously nonresponsive to interferon: a randomized trial

Authors: Poynard T.; Marcellin P.; Bissery A.; Myers R.P.; Moussalli J.; Degos F.; Dhumeaux D.; Riachi G.; Bronowicki J.P.; Brissot P.; Buffet C.; Serfaty L.; Naveau S.; Sogni P.; Beaugrand M.; Gayno S.; Larrey D.; Samuel D.; Eugene C.; Pol S.; Bedossa P.; Daurat V.; Chaumet-Riffaud P.

Source: Journal of Viral Hepatitis, Volume 10, Number 3, May 2003 , pp. 197-204(8)

Publisher: Blackwell Publishing